Noticias de CRVS_US

Noticias del mercado

Últimas noticias sobre CRVS_US — 114 novedades recientes. Análisis, balances, opiniones y cobertura de prensa.

Ticker: CRVS_US ✕ 114 resultados
26/04/2026 CRVS_US — MSN ES ← EN
Las acciones de Corvus Pharma caen más del 6% después del mejor día de su historia: ¿qué salió mal?

Corvus Pharma stock dips over 6% after-hours following best day ever — what went wrong?

25/04/2026 CRVS_US — MarketBeat ES ← EN
Corvus Pharmaceuticals (NASDAQ:CRVS) subió la calificación de Wall Street Zen a "Mantener"

Wall Street Zen elevó las acciones de Corvus Pharmaceuticals de una calificación de "vender" a una calificación de "mantener" en un informe de investigación el sábado.

25/04/2026 CRVS_US — MSN ES ← EN
Corvus salta cuando Goldman Sachs inicia la compra de activo líder

Corvus jumps as Goldman Sachs initiates at buy on lead asset

24/04/2026 CRVS_US — Sahm
Is Corvus Pharmaceuticals (CRVS) Reframing Its Immunology Strategy With Soquelitinib’s Drug‑Free Remission Narrative?
24/04/2026 CRVS_US — MSN ES ← EN
Goldman Sachs inicia la cobertura de Corvus Pharmaceuticals (CRVS) con recomendación de compra

Goldman Sachs initiates coverage of Corvus Pharmaceuticals (CRVS) with buy recommendation

24/04/2026 CRVS_US — MSN ES ← EN
Corvus salta cuando Goldman Sachs inicia la compra de activo líder

Corvus jumps as Goldman Sachs initiates at buy on lead asset

24/04/2026 CRVS_US — ChartMill ES ← EN
Análisis técnico CRVS | Tendencias, señales y patrones de gráficos | CORVUS PHARMACEUTICALS INC (NASDAQ:CRVS)

CRVS Technical Analysis | Trend, Signals & Chart Patterns | CORVUS PHARMACEUTICALS INC (NASDAQ:CRVS)

24/04/2026 CRVS_US — Stock Titan
Corvus Pharmaceuticals (NASDAQ: CRVS) outlines 2026 virtual meeting and pay vote
24/04/2026 CRVS_US — Investing.com India ES ← EN
Corvus Pharmaceuticals nombra a un ex ejecutivo de Genentech para su junta directiva Por Investing.com

Corvus Pharmaceuticals appoints ex-Genentech executive to board By Investing.com

23/04/2026 CRVS_US — MarketBeat ES ← EN
Corvus Pharmaceuticals (NASDAQ:CRVS) cotiza a la baja un 10,2 %: este es el motivo

Las acciones de Corvus Pharmaceuticals (NASDAQ:CRVS) caen un 10,2 % - ¿Qué

23/04/2026 CRVS_US — Investing.com South Africa
Corvus Pharmaceuticals appoints ex-Genentech executive to board By Investing.com
23/04/2026 CRVS_US — Investing.com UK
Corvus Pharmaceuticals appoints ex-Genentech executive to board By Investing.com
23/04/2026 CRVS_US — MarketScreener ES ← EN
Corvus Pharmaceuticals nombra a Andrew C. Chan, M.D., Ph.D., miembro de la junta directiva

Corvus Pharmaceuticals Appoints Andrew C. Chan, M.D., Ph.D., to Board of Directors

23/04/2026 CRVS_US — Stock Titan ES ← EN
El veterano investigador de Genentech, Andrew Chan, se une a la junta directiva de Corvus
23/04/2026 CRVS_US — Yahoo Finance
Corvus Pharmaceuticals Appoints Andrew C. Chan, M.D., Ph.D., to Board of Directors
23/04/2026 CRVS_US — Investing.com Canada
Corvus Pharmaceuticals appoints ex-Genentech executive to board By Investing.com
23/04/2026 CRVS_US — Investing.com
Corvus Pharmaceuticals appoints ex-Genentech executive to board
23/04/2026 CRVS_US — TipRanks
Corvus Pharmaceuticals Announces Board Changes and New Director
23/04/2026 CRVS_US — Stock Titan
New Corvus (NASDAQ: CRVS) director joins as Scott Morrison exits
23/04/2026 CRVS_US — MarketScreener
Corvus Pharmaceuticals, Inc. Appoints Andrew C. Chan to Board of Directors

Página 3 de 6

keyboard_arrow_up